Key result
ATF3 deletion in cardiomyocytes reduced heart growth and dampened fibrosis following transverse aortic constriction, whereas ATF3 ablation in myofibroblasts reduced the hypertrophic gene program.
Why the study?
While transgenic mice with cardiomyocyte ATF3 expression show adverse cardiac remodeling, whole body knockout yielded non-conclusive results, leaving unclear whether cell type-specific ATF3 ablation produces diverse cardiac phenotypes.
Does ablation of ATF3 in cardiomyocytes or myofibroblasts alter the cardiac hypertrophic and fibrotic response to transverse aortic constriction in mice?
Does ablation of ATF3 in cardiomyocytes or myofibroblasts alter the cardiac hypertrophic and fibrotic response to transverse aortic constriction in mice?
Answers are grounded in this paper and cite their sources.
ATF3 expression in the heart plays a key role in the maladaptive response to pressure overload, with distinct roles in cardiomyocytes (promoting cardiac growth and fibrosis) and myofibroblasts (promoting a hypertrophic gene program).
BACKGROUND: Activating transcription 3 (ATF3) is a member of the basic leucine zipper family of transcription factors. ATF3 is an immediate early gene expressed following various cellular stresses. ATF3 acts through binding to cyclic AMP response elements found in the promoters of key regulatory proteins that determine cell fate. In the heart, multiple cardiac stresses result in chronic ATF3 expression. Transgenic mice with ATF3 expression in cardiomyocytes clearly demonstrate that ATF3 serves a leading role in heart hypertrophy, cardiac fibrosis, cardiac dysfunction and death. In contrast, the use of ATF3 whole body knockout mice resulted non-conclusive results. The heart is composed of various cell types such as cardiomyocytes, fibroblasts, endothelial and immune cells. The question that we addressed in this study is whether ablation of ATF3 in unique cell types in the heart results in diverse cardiac phenotypes. METHODS: ATF3-flox mice were crossed with αMHC and Postn specific promoters directing CRE expression and thus ATF3 ablation in cardiomyocytes and myofibroblast cells. Mice were challenged with transverse aortic constriction (TAC) for eight weeks and heart function, ventricle weight, hypertrophic markers, fibrosis markers and ATF3 expression were assessed by qRT-PCR. RESULTS: The results of the study show that ATF3 deletion in cardiomyocytes followed by TAC resulted in reduced heart growth and dampened fibrosis response while ATF3 ablation in myofibroblasts displayed a reduced hypertrophic gene program. CONCLUSIONS: TAC-operation results in increased ATF3 expression in both myofibroblasts and cardiomyocytes that promotes a hypertrophic program and fibrotic cardiac growth, respectively.
No takes yet. Share an insight, caveat, or question.
Abu-Sharki et al. (2020) studied Cardiac remodeling and hypertrophy (pressure overload). ATF3 ablation in cardiomyocytes or myofibroblasts vs. ATF3-flox control mice was evaluated on Ventricle weight to body weight ratio (VW/BW) and hypertrophic/fibrotic gene expression. ATF3 deletion in cardiomyocytes reduced heart growth and dampened fibrosis following transverse aortic constriction, whereas ATF3 ablation in myofibroblasts reduced the hypertrophic gene program.
Synapse has enriched 10 related papers. Consider them for comparative context: